Suchergebnisse
Alcoa Rebounds as Aluminum Tightens, But a Q1 Miss Tests the Rally
Global aluminum industry leader Alcoa (NYSE: AA) has served as the quintessential example of just how highly cyclical the basic materials sector can be.
So far this year, that cohort of stocks has
OCGN Gene Therapy Pipeline: Key 2026-27 Catalysts Ahead
Ocugen OCGN is advancing three one-time gene therapy programs for retinal diseases, each aimed at conditions with large unmet needs and limited effective options.
The company’s late-stage calendar
Ocugen Stock Outlook: Valuation, Cash Runway and Dilution Risk
Ocugen OCGN is advancing a late-stage ophthalmology pipeline built around one-time gene therapies for retinal diseases with large unmet needs. Multiple clinical readouts and regulatory milestones
Earnings Estimates Moving Higher for State Street (STT): Time to Buy?
Investors might want to bet on State Street Corporation (STT), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price
Titanbay erweitert seinen Schweizer Beirat mit der Ernennung von Adrian Nösberger
Der ehemalige CEO der Schroder & Co Bank AG und Präsident des Verbands der Auslandsbanken in der Schweiz verstärkt den Beirat angesichts der steigenden Nachfrage nach Infrastruktur für Private
Deere (DE) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Deere (DE) closed at $579.99, marking a -1.24% move from the previous day. This change lagged the S&P 500's daily gain of 1.05%. At the same time, the Dow added 0.69%
Caterpillar (CAT) Stock Moves 1.05%: What You Should Know
In the latest trading session, Caterpillar (CAT) closed at $808.87, marking a +1.05% move from the previous day. The stock's performance was in sync with S&P 500. At the same time, the Dow added
Dynatrace (DT) Laps the Stock Market: Here's Why
Dynatrace (DT) closed the most recent trading day at $36.14, moving +1.18% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 1.05%. At the same time
Trip.com (TCOM) Stock Slides as Market Rises: Facts to Know Before You Trade
Trip.com (TCOM) closed the most recent trading day at $53.95, moving -1.28% from the previous trading session. This change lagged the S&P 500's daily gain of 1.05%. At the same time, the Dow added
Wichtige operative Meilensteine auf dem Weg zum Produzenten erreicht!
Beliebte Arten von Live-Wetten auf der Plattform Stawkibet
3 Top-Ranked Mutual Funds for Your Retirement
There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.
The best way to
Make the Most of Your Retirement with These Top-Ranked Mutual Funds
There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.
The easiest, most
Apple's Leadership Change to Boost AI Integration? ETFs in Focus
Apple AAPL is entering a pivotal phase as CEO Tim Cook prepares to step down on Sept. 1, ending a 15-year tenure. He will be succeeded by longtime hardware chief John Ternus, marking only the second
Despite Fast-paced Momentum, Under Armour (UAA) Is Still a Bargain Stock
Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that
Fast-paced Momentum Stock TD SYNNEX (SNX) Is Still Trading at a Bargain
Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that
Here's What Could Help Private Bancorp of America (PBAM) Maintain Its Recent Price Strength
While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure
If You Invested $1000 in Fabrinet 10 Years Ago, This Is How Much You'd Have Now
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and
Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q1 Earnings
While Eli Lilly LLY is a market leader in the GLP-1 segment, thanks to its tirzepatide medicines Mounjaro (for diabetes) and Zepbound (for obesity), the company also generates a meaningful portion
WEX Inc. (WEX) Soars to 52-Week High, Time to Cash Out?
Shares of Wex (WEX) have been strong performers lately, with the stock up 22.2% over the past month. The stock hit a new 52-week high of $186.86 in the previous session. Wex has gained 24.1% since




